Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

CTL1 is a potential therapeutic target in glioma

April 1, 2020

China's NMPA clears IND for trials of NTRK/ROS1 inhibitor HG-030

April 1, 2020

New RET inhibitors discovered at Array BioPharma

April 1, 2020

European Commission approves Nubeqa for nonmetastatic castration-resistant prostate cancer

March 31, 2020

Golden Biotech advances phase I/II study of antroquinonol for stage IV metastatic pancreatic cancer

March 31, 2020

HMPL-453 begins new phase II study in China for advanced malignant mesothelioma

March 31, 2020

Chengdu Origin Biotechnology discovers proteosome inhibitors

March 31, 2020

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents BTK inhibitors

March 31, 2020

New serine-protein kinase ATM inhibitors disclosed by Suzhou Zanrong Pharma

March 31, 2020

Abbisko Therapeutics identifies new fibroblast growth factor receptor inhibitors

March 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...